Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
Jun-Ichi NishimuraKensuke UsukiJulia RamosSatoshi IchikawaMuriel BuriAnna KiialainenAlexandre SostellyRégis Peffault de LatourIdo Paz-PrielAlexander RöthPublished in: British journal of haematology (2022)